Neogen Corporation (FRA:NG2)

Market Cap	1.87B -21.9%
Revenue (ttm)	759.19M -3.7%
Net Income	-519.80M
EPS	-2.40
Shares Out	n/a
PE Ratio	n/a
Forward PE	29.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	183
Open	8.45
Previous Close	8.30
Day's Range	8.45 - 8.45
52-Week Range	4.00 - 11.30
Beta	n/a
RSI	71.85
Earnings Date	Jan 8, 2026

About Neogen

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanita...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 2,974
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NG2

Financial Performance

In fiscal year 2025, Neogen's revenue was $894.66 million, a decrease of -3.20% compared to the previous year's $924.22 million. Losses were -$1.09 billion, 11491.6% more than in 2024.

Financial numbers in USD